Studies have shown that high expression of BCL10 promotes liver cell proliferation and migration via activation of the AKT signaling pathway, reducing cell apoptosis, and is associated with poor prognosis of the tumor microenvironment (76). The gene discussed is AKT1; the disease is neoplasm.